Paul Nuyujukian
👤 SpeakerAppearances Over Time
Podcast Appearances
The problem right now is that there's not a single device currently medically approved used for any routine clinical purpose that measures individual neurons.
We don't record the brain to treat brain disease.
Instead, what we've been doing up until this point is
Studying proxies, right?
Downstream effects of that brain injury.
I liken it to treating diabetes.
Imagine we were trying to treat diabetes.
We know that there's a disease.
We know it has something to do with insulin.
But the way which we're dosing insulin is by looking at the person and saying, oh, do you feel really tired?
Or are you sweating?
Or are you about to faint?
And we're not measuring a blood sugar.
And that's sort of where we are right now in brain diseases.
We don't record from the brain.
We look at downstream proxies of it.
And there's reasons for this, right?
I understand why.
It's surgery involved.
It's challenging.